Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Edwards Lifesciences Corp Director's Dealing 2021

May 11, 2021

30042_dirs_2021-05-11_3ac0bc64-cd7d-4c66-a263-f8fe77254a03.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-05-07

Reporting Person: Lemercier Jean-Luc M (CVP, EMEA, Canada, Latin Amer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-07 Common Stock F 51.0000 $91.7500 Disposed 142340.1380 Direct